Pericardial effusion in cancer patients is a marker of advanced disease and poor prognosis, requiring prompt diagnosis and tailored management.
Association with advanced cancer stage warrants vigilance in oncology; leaves open prospective evaluation of effusion management.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Fernandes et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: